肝纤维化内科治疗的研究  

The research on medical treatment of liver fibrosis

作　　者：陈鲜兰[1,2] 李小安[2] 

机构地区：[1]泸州医学院,四川泸州646000 [2]成都军区总医院消化科

出　　处：《胃肠病学和肝病学杂志》2010年第1期93-95,共3页Chinese Journal of Gastroenterology and Hepatology

摘　　要：肝纤维化是各种慢性肝病向肝硬化发展的中间病理过程。此过程是一动态过程,是可逆性的。目前许多学者研究发现给予药物治疗、基因治疗、干细胞移植等方法能有效预防肝纤维化的发生、延缓肝纤维化的进展或使肝纤维化逆转。Liver fibrosis is a middle pathological process which many chronic liver diseases turn to liver cirrhosis.This process is a dynamic state process and it can be reversed.The current study finds that many scholars can prevent effectively the occurrence of liver fibrosis and delay the progress of liver fibrosis or reverse it by drug therapy,gene therapy and stem cell transplantation.

关 键 词：肝纤维化 药物治疗 基因治疗 干细胞移植 

分 类 号：R574.62[医药卫生—消化系统] R392.11[医药卫生—内科学]